<p>Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease</p>
Male
0301 basic medicine
Medicine (General)
Polyesters
Polysorbates
blood brain barrier
PC12 Cells
Polyethylene Glycols
Rats, Sprague-Dawley
03 medical and health sciences
R5-920
International Journal of Nanomedicine
Alzheimer Disease
Animals
Tissue Distribution
Original Research
Neurons
alzheimer’s disease
neuroprotective effect
Oxindoles
Rats
3. Good health
Mice, Inbred C57BL
Disease Models, Animal
Neuroprotective Agents
Blood-Brain Barrier
rhynchophylline
Nanoparticles
nanoparticles
Rabbits
DOI:
10.2147/ijn.s236922
Publication Date:
2020-02-17T19:24:56Z
AUTHORS (7)
ABSTRACT
Alzheimer's disease (AD) is a growing concern in the modern society. The current drugs approved by FDA are not very promising. Rhynchophylline (RIN) is a major active tetracyclic oxindole alkaloid stem from traditional Chinese medicine uncaria species, which has potential activities beneficial for the treatment of AD. However, the application of rhynchophylline for AD treatment is restricted by the low water solubility, low concentration in brain tissue and low bioavailability. And there is no study of brain-targeting therapy with RIN. In this work, we prepared rhynchophylline loaded methoxy poly (ethylene glycol)-poly (dl-lactide-co-glycolic acid) (mPEG-PLGA) nanoparticles (NPS-RIN), which coupled with Tween 80 (T80) further for brain targeting delivery (T80-NPS-RIN).Preparation and characterization of T80-NPS-RIN were followed by the detection of transportation across the blood-brain barrier (BBB) model in vitro, biodistribution and neuroprotective effects of nanoparticles.The results indicated T80-NPS-RIN could usefully assist RIN to pass through the BBB to the brain. T80-NPS-RIN treatment regulated the activity of neurons in vitro.The presented data confirmed that rhynchophylline encapsulated mPEG-PLGA nanoparticles coated with Tween 80 could across through the BBB and exhibited efficient neuroprotective effects. The T80-NPS-RIN nanoparticles have a chance to be an alternative drug to the therapy of AD.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (31)
CITATIONS (72)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....